Annual accounts 2021 filedPDFabbreviated format · 68 days before the deadline
1 director appointed, 1 resignationName hiddenVisible after signing in resigns · Hidden nameVisible after signing in appointed · Name after signing inVisible after signing in acts as permanent representative · General meeting of 30-03-20224 points ▸
General meeting, 30-03-2022
Director resignation, Name hiddenVisible after signing in
Director appointment, Hidden nameVisible after signing in
Permanent representative, Name after signing inVisible after signing in
Annual accounts 2020 filedPDFabbreviated format · 18 days late
2020
Highest result from 2006 to 2025net €87,267 ▲261% The net result of €87,267 is the highest of those years.
Liquidity more than doubledcurrent ratio 5.40 The current ratio rises from 2.58 to 5.40. Short-term debt falls from €156,897 to €59,779.
Annual accounts 2019 filedPDFabbreviated format · 32 days before the deadline
2019
Annual accounts 2018 filedPDFabbreviated format · 29 days before the deadline
2018
Annual accounts 2017 filedPDFabbreviated format · 7 days before the deadline
Capital increaseAfter the increase, the capital stands at €217,246.99 · The capital fell from €217,246.99 to €76,846.99 · The capital fell from €76,846.99 to €20,0006 points ▸
Each sentence rests on a document from the KBO register, the Belgian Official Gazette or the National Bank. The number after the sentence opens that document.
On 22 August 1985, ALMAPHARMA was incorporated.1The capital was increased 2 times between 2014 and 2018, most recently to €217,247.23The name was changed to ALMAPHARMA in 2024.4Name hiddenVisible after signing in is director of the company, appointed by deed of 26-04-2022.5Total assets went from €386,038 in 2018 to €515,565 in 2025 and headcount from 1.1 to 2.2 full-time equivalents.6